000 01662 a2200469 4500
005 20250515175158.0
264 0 _c20100629
008 201006s 0 0 eng d
022 _a1476-5462
024 7 _a10.1038/gt.2009.77
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSeregin, S S
245 0 0 _aCR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies.
_h[electronic resource]
260 _bGene therapy
_cOct 2009
300 _a1245-59 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aAnimals
650 0 4 _aB-Lymphocytes
_ximmunology
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aDown-Regulation
_ximmunology
650 0 4 _aGenetic Vectors
650 0 4 _aImmunity, Innate
650 0 4 _aImmunoglobulins
_xbiosynthesis
650 0 4 _aLiver
_xmetabolism
650 0 4 _aLymphocyte Activation
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aReceptors, Complement
_ximmunology
650 0 4 _aReceptors, Complement 3d
_ximmunology
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
_xmethods
700 1 _aAldhamen, Y A
700 1 _aAppledorn, D M
700 1 _aSchuldt, N J
700 1 _aMcBride, A J
700 1 _aBujold, M
700 1 _aGodbehere, S S
700 1 _aAmalfitano, A
773 0 _tGene therapy
_gvol. 16
_gno. 10
_gp. 1245-59
856 4 0 _uhttps://doi.org/10.1038/gt.2009.77
_zAvailable from publisher's website
999 _c18971534
_d18971534